Related Experiment Videos
Bone marrow acid phosphatase in staging prostatic carcinoma
The Journal of Urology
|September 11, 1975
Summary
Bone marrow acid phosphatase is a reliable tool for staging prostatic carcinoma. This test accurately identified metastatic disease in 4 patients, proving useful in cancer staging.
Area of Science:
- Oncology
- Biochemistry
Background:
- Prostatic carcinoma staging is crucial for treatment planning.
- Accurate staging requires reliable diagnostic parameters.
Purpose of the Study:
- To evaluate bone marrow acid phosphatase as a parameter for staging prostatic carcinoma.
- To assess the reliability and utility of this method in clinical practice.
Main Methods:
- Bone marrow acid phosphatase levels were measured in 30 patients with prostatic carcinoma.
- The results were analyzed in the context of cancer staging.
Main Results:
- Bone marrow acid phosphatase measurement proved to be a reliable method.
- No false positive results were observed.
- The test indicated metastatic disease in 4 patients, serving as the sole indicator in these cases.
Conclusions:
- Bone marrow acid phosphatase is a valuable addition to prostatic carcinoma staging procedures.
- This biochemical marker aids in identifying metastatic disease.